IL1B and cancer: Previously identified targets of oidiolactones and closely related analogs associated with their anti-cancer activities include IL-1β and TNF-ɑ [76], while the nagilactones and podolactones were found to induce apoptosis [74], inhibit protein synthesis [77], and inhibit transcription factor AP-1, activator protein 1 [78,79].